CoChat

Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential

Sinclair, Elaine M, Drucker, Daniel J. · 2005 · Physiology
Cited by 87

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the peptides for the treatment of human disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/physiol.00030.2005

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 101

  1. 10.1016/S0014-2999(00)00600-2 · DOI · Paper page
  2. 10.1053/jpsu.2000.6861 · DOI
  3. 10.1097/00006676-200005000-00003 · DOI · Paper page
  4. 10.2337/diabetes.53.9.2492 · DOI · Paper page
  5. 10.1016/0167-0115(88)90099-7 · DOI
  6. 10.1007/s001250051445 · DOI · Paper page
  7. 10.1152/ajpendo.1994.266.3.E459 · DOI · Paper page
  8. 10.1136/gut.47.1.112 · DOI · Paper page
  9. 10.2337/diabetes.54.1.146 · DOI · Paper page
  10. 10.1152/ajpendo.1999.277.5.E937 · DOI · Paper page
  11. 10.1007/BF00400461 · DOI
  12. 10.1210/endo.138.11.5482 · doi:10.1210/endo.138.11.5482 · Paper page
  13. 10.1152/ajpendo.1997.272.6.E1050 · DOI · Paper page
  14. 10.1210/en.2004-1119 · DOI
  15. 10.1152/ajpgi.2000.279.6.G1249 · DOI · Paper page
  16. 10.2337/diabetes.52.1.124 · DOI · Paper page
  17. 10.2337/diabetes.50.10.2237 · DOI · Paper page
  18. 10.1152/ajpgi.00231.2002 · DOI · Paper page
  19. 10.1210/endo.134.5.8156917 · doi:10.1210/endo.134.5.8156917 · Paper page
  20. 10.1152/ajpgi.1996.271.3.G477 · DOI · Paper page
  21. 10.1210/jc.2003-030421 · DOI · Paper page
  22. 10.1053/gast.1997.v112.pm9178688 · DOI
  23. 10.1210/endo.142.10.8430 · DOI · Paper page
  24. 10.2337/diabetes.52.2.365 · DOI · Paper page
  25. 10.2337/diab.44.9.1126 · DOI · Paper page
  26. DhanvantariS, Seidah NG, and Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon.Mol Endocrinol10: 342–355, 1996. · doi:10.1210/mend.10.4.8721980 · Paper page
  27. 10.1210/me.2002-0306 · DOI · Paper page
  28. 10.1073/pnas.93.15.7911 · DOI · Paper page
  29. 10.1038/nbt0797-673 · DOI · Paper page
  30. 10.1152/ajpgi.1999.276.1.G79 · DOI · Paper page
  31. 10.1055/s-2004-826159 · DOI · Paper page
  32. 10.1016/S0303-7207(98)00096-3 · DOI · Paper page
  33. 10.1210/en.2004-1389 · DOI
  34. 10.1210/endo.130.1.1309325 · doi:10.1210/endo.130.1.1309325 · Paper page
  35. FurutaM, Yano H, Zhou A, Rouille Y, Holst JJ, Carroll R, Ravazolla M, Orci L, Furuta H, and Steiner DF. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.Proc Natl Acad Sci USA94: 6646–6651, 1999. · DOI · Paper page
  36. 10.1073/pnas.0237106100 · DOI · Paper page
  37. 10.1074/jbc.M209165200 · DOI · Paper page
  38. 10.1210/en.2003-0007 · DOI · Paper page
  39. 10.1016/S0016-5085(03)00667-X · DOI · Paper page
  40. 10.1080/003655202317316006 · DOI
  41. 10.1152/ajpendo.00197.2004 · DOI · Paper page
  42. 10.1016/0196-9781(95)00078-X · DOI
  43. 10.2337/diacare.27.8.1915 · DOI · Paper page
  44. HartmannB, Harr MB, Jeppesen PB, Wojdemann M, Deacon CF, Mortensen PB, and Holst JJ. In vivo and in vitro degradation of glucagon-like peptide-2 in humans.J Clin Endocrinol Metab85: 2884–2888, 2000. · DOI · Paper page
  45. 10.1016/0014-5793(85)80879-6 · DOI
  46. 10.1210/endo-115-1-102 · DOI
  47. 10.1126/science.8384375 · DOI · Paper page
  48. 10.1053/gast.2001.22555 · DOI · Paper page
  49. 10.1126/science.6278587 · DOI · Paper page
  50. 10.1111/j.1469-7793.2001.0375c.xd · DOI · Paper page
  51. 10.1074/jbc.M108378200 · DOI · Paper page
  52. 10.2337/diabetes.52.3.751 · DOI · Paper page
  53. 10.1523/JNEUROSCI.22-23-10470.2002 · DOI · Paper page
  54. 10.1038/297156a0 · DOI
  55. 10.1210/me.2004-0196 · DOI
  56. 10.1210/jc.2002-021545 · DOI · Paper page
  57. 10.2337/diabetes.51.3.691 · DOI · Paper page
  58. 10.2337/diabetes.53.2.410 · DOI · Paper page
  59. 10.1007/s004280000374 · DOI
  60. 10.2337/diacare.27.6.1335 · DOI · Paper page
  61. 10.1073/pnas.120069197 · DOI · Paper page
  62. 10.1124/pr.55.1.6 · DOI · Paper page
  63. 10.1016/0167-0115(93)90435-B · DOI · Paper page
  64. 10.1073/pnas.96.4.1569 · DOI · Paper page
  65. 10.1007/BF02934484 · DOI
  66. 10.1006/bbrc.2001.4999 · DOI
  67. 10.1016/0026-0495(95)90288-0 · DOI
  68. 10.1016/j.regpep.2004.07.009 · DOI · Paper page
  69. 10.1210/endo-119-4-1467 · DOI · Paper page
  70. 10.1210/endo-123-4-2009 · DOI · Paper page
  71. 10.2337/diab.47.8.1253 · DOI · Paper page
  72. 10.1007/s001250100006 · DOI · Paper page
  73. 10.1053/jpsu.2001.22284 · doi:10.1053/jpsu.2001.22284
  74. 10.1016/S0022-3468(00)90040-X · DOI
  75. 10.2337/diabetes.53.12.3267 · DOI · Paper page
  76. 10.1210/endo.140.4.6643 · doi:10.1210/endo.140.4.6643 · Paper page
  77. 10.1074/jbc.270.17.10136 · DOI · Paper page
  78. 10.1073/pnas.91.8.3242 · DOI · Paper page
  79. 10.1139/y90-239 · DOI · Paper page
  80. 10.1007/BF01538078 · DOI
  81. 10.1111/j.1365-2362.1988.tb01046.x · DOI · Paper page
  82. 10.1152/ajpgi.1998.275.5.G911 · DOI · Paper page
  83. 10.1080/003655201750422648 · DOI
  84. 10.1053/j.gastro.2005.02.033 · DOI
  85. 10.1210/endo.137.11.8895391 · DOI · Paper page
  86. 10.2337/diabetes.49.7.1156 · DOI · Paper page
  87. 10.1172/JCI20911 · doi:10.1172/jci20911 · Paper page
  88. 10.1016/0303-7207(94)90162-7 · DOI
  89. 10.1006/jsre.2000.5917 · DOI
  90. 10.1152/ajpendo.2000.278.1.E134 · DOI · Paper page
  91. 10.2337/diab.42.11.1678 · DOI · Paper page
  92. 10.1016/S0167-0115(01)00316-0 · DOI
  93. 10.1007/s00125-005-1692-8 · DOI
  94. 10.1080/00365529850171486 · DOI · Paper page
  95. 10.1016/S0016-5085(99)70555-X · DOI · Paper page
  96. YewKH, Hembree M, Prasadan K, Preuett B, McFall C, Benjes C, Crowley A, Sharp S, Tulachan S, Mehta S, Tei E, and Gittes G. Crosstalk between BMP and TGF-beta signaling is essential for exendin-4 induced insulin-positive differentiation of AR42J cells.J Biol Chem. In press.
  97. 10.1074/jbc.M005510200 · DOI
  98. 10.1074/jbc.M201358200 · DOI
  99. 10.1053/gast.2000.16489 · DOI · Paper page
  100. 10.1074/jbc.274.43.30459 · DOI · Paper page
  101. 10.2337/diabetes.48.12.2358 · DOI · Paper page

Cited by

See all 87

Metadata

Authors
Sinclair, E. M., & Drucker, D. J.
Venue
Physiology
Published
2005-10
Volume
20
Issue
5
Pages
357-365
ISSN
  • 0886-1714 (ISSN-L)
  • 1548-9213
  • 1548-9221
OpenAlex
W2088954563
Cited by
87
References
28
FWCI
4.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.